(NASDAQ: ANNX) Annexon's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.64%.
Annexon's earnings in 2026 is -$198,333,000.On average, 13 Wall Street analysts forecast ANNX's earnings for 2026 to be -$160,156,081, with the lowest ANNX earnings forecast at -$183,044,883, and the highest ANNX earnings forecast at -$147,949,812. On average, 13 Wall Street analysts forecast ANNX's earnings for 2027 to be -$136,398,913, with the lowest ANNX earnings forecast at -$205,524,080, and the highest ANNX earnings forecast at -$60,556,202.
In 2028, ANNX is forecast to generate -$4,046,911 in earnings, with the lowest earnings forecast at -$142,903,462 and the highest earnings forecast at $239,128,184.